Interstitial Lung Disease (ILD) Clinical Trials

12 recruiting

Interstitial Lung Disease (ILD) Trials at a Glance

12 actively recruiting trials for interstitial lung disease (ild) are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Granollers, Beijing, and Beijing. Lead sponsors running interstitial lung disease (ild) studies include Hospital de Granollers, Erasmus Medical Center, and Dai Huaping.

Browse interstitial lung disease (ild) trials by phase

Treatments under study

About Interstitial Lung Disease (ILD) Clinical Trials

Looking for clinical trials for Interstitial Lung Disease (ILD)? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Interstitial Lung Disease (ILD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Interstitial Lung Disease (ILD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 2

Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

Interstitial Lung Disease (ILD)
Region Skane20 enrolled2 locationsNCT07398287
Recruiting
Phase 2

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting
Not Applicable

Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial

Interstitial Lung Disease (ILD)Suspected Interstitial Lung Disease
Hospital de Granollers92 enrolled1 locationNCT07482917
Recruiting
Not Applicable

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

Interstitial Lung Disease (ILD)
Hospital de Granollers152 enrolled1 locationNCT07486206
Recruiting
Not Applicable

Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease

Lung BiopsyInterstitial Lung Disease (ILD)
University of Zurich30 enrolled2 locationsNCT07500818
Recruiting

Implementation of digitally-supported self-management and pulmonary rehabilitation in people with chronic respiratory disease

AsthmaChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+1 more
Northern Sydney Local Health District138 enrolled3 locationsACTRN12626000197336
Recruiting
Phase 1

A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Interstitial Lung Disease

Healthy VolunteersInterstitial Lung Disease (ILD)
Ruijin Hospital84 enrolled1 locationNCT06992661
Recruiting
Phase 4

A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease

Interstitial Lung Disease (ILD)Connective Tissue Disease-associated Interstitial Lung Disease
Peking University Third Hospital100 enrolled1 locationNCT07319598
Recruiting
Not Applicable

Routine vs On-demand ECMO for Lung Transplantation

Respiratory FailurePulmonary FibrosisInterstitial Lung Disease (ILD)
Centre hospitalier de l'Université de Montréal (CHUM)218 enrolled4 locationsNCT06615492
Recruiting
Not Applicable

Implementation of Home Monitoring in Patients With Pulmonary Fibrosis

Pulmonary FibrosisInterstitial Lung Disease (ILD)
Erasmus Medical Center220 enrolled11 locationsNCT06883448
Recruiting

AYLo - AutoimmunitY and Loss of y

Asthma BronchialeCOPDSarcoidosis+10 more
University of Bonn500 enrolled1 locationNCT06696027
Recruiting

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Interstitial Lung Disease (ILD)
Dai Huaping10,000 enrolled1 locationNCT06655090